US 11780930
CD38 modulating antibody
granted A61KA61K2039/505A61P
Quick answer
US patent 11780930 (CD38 modulating antibody) held by BLACK BELT THERAPEUTICS LIMITED expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BLACK BELT THERAPEUTICS LIMITED
- Grant date
- Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00